Biosimulation Industry Forecast, 2029: Analysis of Case Studies, Market Dynamics, Regional Growth Trends, Regulatory Landscape, Value Chain, and Competitive Intelligence
12 déc. 2024 05h02 HE
|
Research and Markets
Dublin, Dec. 12, 2024 (GLOBE NEWSWIRE) -- The "Biosimulation Market Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.The biosimulation market is projected to reach USD...
Certara Showcases 2024 Research Wins With Over 100 Papers Published
02 déc. 2024 16h15 HE
|
Certara
RADNOR, Pa., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today showcases its impact on research by celebrating more than 100...
Certara Appoints John Reynders as New Independent Board Member
16 oct. 2024 16h15 HE
|
Certara
Certara today announced the appointment of John Reynders, PhD to its Board of Directors, effective October 15, 2024.
Certara Completes Acquisition of Chemaxon
02 oct. 2024 16h15 HE
|
Certara
Certara completes acquiring Chemaxon, a leading cheminformatics company that develops scientific informatics software used by the life sciences industry.
Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug
18 sept. 2024 08h00 HE
|
Certara
Certara shared the results from its collaboration with Ichnos Glenmark Innovation (IGI) on the first-in-human dose prediction and selection for ISB 2001.
Certara Launches Phoenix™ Version 8.5 Drug Development Software
15 août 2024 16h15 HE
|
Certara
Certara today announced the launch of Phoenix™ version 8.5 software, the pharmaceutical industry's gold standard in PK/PD modeling and simulation.
Certara Appoints New Chief Human Resources Officer & General Counsel
21 mai 2024 08h00 HE
|
Certara
Certara has appointed Rona Anhalt as Chief Human Resources Officer and Daniel Corcoran as General Counsel.
Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform
16 avr. 2024 08h00 HE
|
Certara
Certara Cloud is a unifying platform that integrates Certara's scientific software. Clients use a single ID to access and manage their licensed software.
Global Biosimulation Market to Surge, Predicted CAGR of 16.98% from 2024 to 2034, Driven by Pharmaceutical R&D and Technological Advancements
29 janv. 2024 10h53 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Global Biosimulation Market" report has been added to ResearchAndMarkets.com's offering. The advent of cutting-edge biosimulation technologies is...
Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies
13 déc. 2023 16h30 HE
|
Certara
Combined Certara-Applied Biomath organization establishes the life sciences industry’s largest quantitative systems pharmacology center.